BIO-Europe 2026

Talk · Presenting Companies (Theatre B)

Metabolic Diseases: Guangzhou Innogen Pharmaceutical Group Co., Ltd.

QINGHUA WANG, Guangzhou Innogen Pharmaceutical Group Co., Ltd.

Workshop · Welcome to BIO-Europe · Clinical Strategy Stage

Newcomer's Program

Workshop · Workshop A · Regulatory Strategy Stage

Build, Buy, or Partner? Choosing Your Market Entry Strategy

Pankaj Oza, Blue Matter Consulting · Begona Carreno, Idorsia · Carter King, Protagonist Therapeutics · Anton Shchesniak, Biogen

Workshop · Workshop B · Biomanufacturing Strategy Stage

Doctor-to-Doctor: A PI-Led Pathway into Japan Using AI, DCT, and Registration-Directed Investigator-Initiated Trials to Reach Japanese Patients Faster

Shinya Yamamoto, Deep Intelligent Pharma K.K. (DIP)

Workshop · Workshop C · Industry Voices Stage

Building Your BD Career: What Really Moves the Needle

Michel de Baar, Thuja Capital · Gregor Fachinger, Merck KGaA · Ingo Lehrke, Tubulis · Angele Maki, Ability Biotherapeutics

Workshop · Workshop D · Ecosystem Innovation Stage

Pitch, Present, Persuade: Become a Powerful Corporate Communicator

Mary Clark, Optimum Communications

Talk · Presenting Companies (Theatre B)

Drug Discovery and Development: Medicus Pharma Ltd

Faisal Mehmud, Medicus Pharma Ltd

Workshop · Welcome to BIO-Europe · Meet at Clinical Strategy Stage

Around the World Exhibit Hall Tour

Talk · Presenting Companies (Theatre B)

Ophthalmology: Hong Kong Haixi Pharmaceuticals Ltd

Ming Zhang, Hong Kong Haixi Pharmaceuticals Ltd

Talk · Relax and Learn (Theatre A)

partneringONE essentials workshop

Asha Ibrahim, partneringOne

Talk · Presenting Companies (Theatre B)

Autoimmune/Inflammation: Henan EMICRO Biomedicine Co., Ltd.

Zhen Pang, Henan EMICRO Biomedicine Co., Ltd.

Talk · The Big Picture Plenary Series · The Big Picture Stage

Audience icebreaker activities

Claire Macht, Informa

Talk · The Big Picture Plenary Series · The Big Picture Stage

Opening Remarks

Claire Macht, Informa · Mona Neubaur, Economic Affairs, Industry, Climate Action and Energy of the State of North Rhine Westphalia · Elizabeth Civils, Biotechnology Innovation Organization

Panel · The Big Picture Plenary Series · The Big Picture Stage

Building a Biotech in a Changing World – Europe’s Choices

Jeremy M. Levin, Ovid Therapeutics Inc · Edwin Moses, NanoSyrinx, LabGenius, and Avantium NV

Panel · The Big Picture Plenary Series · The Big Picture Stage

Unlocking Pharma’s Productivity Potential

Daniel Chancellor, Norstella · Hakan Goker, M Ventures · Geraldine Ng, Novo · Kiran Reddy, Blackstone Life Sciences · Steffen Thirstrup, European Medicines Agency

Keynote · The Big Picture Plenary Series · The Big Picture Stage

Building a competitive and impactful European biotech community: Perspectives from the European Life Sciences Coalition, Argenx and Tubulis

Melanie Senior, Nature portfolio; Evaluate · Regina Hodits, Angelini Ventures · Olivier Litzka, Andera Partners · Ingo Lehrke, Tubulis · Arjen Lemmen, Argenx

Panel · Business of Biotech · Business of Biotech Stage

Navigating partnering and business development in a shifting global landscape

Kipp Kreutzberg, Syneos Health · Fraser Hall, Biogen · Peter Louwagie, Genmab · Miki Nakamori, Astellas · Stephen Pitt, CSL Behring · Partha Ray, Ipsen

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

Open Innovation in Action: How Pharma Is Rewiring the Drug Discovery Ecosystem

Stephen Rapundalo, Michigan Biosciences Industry Association · Khatereh Ahmadi, XGEN Venture · Martin Svorc, Merck KGaA · Markus Koester, Boehringer Ingelheim

Talk · Presenting Companies (Theatre A)

Oncology: Blue Earth Therapeutics

David Gauden, Blue Earth Therapeutics

Talk · Presenting Companies (Theatre B)

Cell and Gene Therapies: SanBio Company Limited

Keita Mori, SanBio Company Limited

Panel · Therapeutic Insights · Therapeutic Insights Stage

The therapeutic landscape backed by analyst insights

Michel de Baar, Thuja Capital · Mary Jane Hinrichs, Ipsen · Giovanni Mariggi, Medicxi · Sara Mallatt, AlphaSense

Talk · Presenting Companies (Theatre A)

Oncology: Bold Therapeutics Inc.

Jim Pankovich, Bold Therapeutics Inc.

Talk · Presenting Companies (Theatre B)

Cell and Gene Therapies: Stand Up Therapeutics Inc.

Junsang Yoo, Stand Up Therapeutics Inc.

Talk · Presenting Companies (Theatre A)

Oncology: Ymmunobio AG

Peter Schiemann, Ymmunobio AG

Talk · Presenting Companies (Theatre B)

Cell and Gene Therapies: Surginex

Seung-Min Yang, Surginex

Talk · Presenting Companies (Theatre A)

Oncology: FoRx Therapeutics AG

Tarig Bashir, FoRx Therapeutics AG

Talk · Presenting Companies (Theatre B)

Biomarkers/Diagnostics/Imaging: SeNostic GmbH

Joachim Glaubitz, SeNostic GmbH

Panel · Business of Biotech · Business of Biotech Stage

Voices from the IPO Class of ’25/’26: What’s Next?

Joachim Eeckhout, European Biotechnology Magazine · Mathieu Pieronne, Andera Life Sciences · Marten Steen, HealthCap · Paul van der Horst, Agomab

Roundtable · Community Conversations · Seated Lunch Area (Hall 7)

Community Conversations – Session 1

Raun Kupiec, R Kupiec Consulting · Mark Reid, Graythan Regulatory · Dan Stanton, Sartorius · Stuart Tindal, Sartorius · Dave Thomas, Venture Valuation · Tony Jones, One Nucleus · Oliver Schacht, Life Science Nord · Anthony Horning, Strategic Transactions Advisory AG · Adrien Horning, Strategic Transactions Advisory AG

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

Get in the Mix with Canada’s Picks: Innovation in Life Sciences

Vera Alexander, Government of Canada · Victor Fedeli, Ontario · Silke Ditgen, Global Affairs Canada · Wendy Hurlburt, Life Sciences BC · Catherine Lunardi, GENAIZ · Karen von Zitzewitz, Sustained Therapeutics · Kevin Sullivan, 3DBioFibR · Nick Kadysh, Restora Neuroscience

Talk · Presenting Companies (Theatre A)

Oncology: Greenwich LifeSciences

Snehal Patel, Greenwich LifeSciences

Talk · Presenting Companies (Theatre B)

Drug Delivery: Huonslab

Byung Ha Lee, Huonslab

Panel · Therapeutic Insights · Therapeutic Insights Stage

ADCs in oncology: What does the data show?

Sophie Hughes, Seroba · Chris Brown, GSK · Jose Mesa, Columbus Venture Partners · Christian Rohlff, Oxford BioTherapeutics · Valerie Vanhooren, Ona Therapeutics

Talk · Presenting Companies (Theatre A)

Oncology: MEDiC Life Sciences

Kyuho Han, MEDiC Life Sciences

Talk · Presenting Companies (Theatre B)

Drug Delivery: NovoArc GmbH

Tanja Krainz, NovoArc GmbH

Fireside chat · Ecosystem Innovation · Ecosystem Innovation Stage

Cracking the Translation Gap: Lessons from Germany’s Coordinated Translational Research Model

Ursula Turcke, FGK Clinical Research · Stefanie Dimmeler, German Centers for Health Research (DZG) · Heiko Lickert, Viacure GmbH

Talk · Presenting Companies (Theatre A)

Oncology: Pin Therapeutics

Hyunsun Jo, Pin Therapeutics

Talk · Presenting Companies (Theatre B)

Drug Discovery and Development: Orbis Medicines ApS

Romain Lalandes, Orbis Medicines ApS

Talk · Presenting Companies (Theatre A)

Immuno-Oncology: Txinno Bioscience Inc.

Sean Ham, Txinno Bioscience Inc.

Talk · Presenting Companies (Theatre B)

Drug Discovery and Development: Portrai, Inc.

Yong Kim, Portrai, Inc.

Fireside chat · Business of Biotech · Business of Biotech Stage

Unpacking the deal

Andreas Zaby, SPRIND GmbH · Christoph Broja, EQT Life Sciences · Ingo Lehrke, Tubulis

Roundtable · Community Conversations · Seated Lunch Area (Hall 7)

Community Conversations – Session 2

Raun Kupiec, R Kupiec Consulting · Mark Reid, Graythan Regulatory · Dan Stanton, Sartorius · Stuart Tindal, Sartorius · Dave Thomas, Venture Valuation · Tony Jones, One Nucleus · Oliver Schacht, Life Science Nord · Anthony Horning, Strategic Transactions Advisory AG · Adrien Horning, Strategic Transactions Advisory AG

Talk · Ecosystem Innovation · Ecosystem Innovation Stage

Merck's EMEA Advance Biotech Grant Program

Adam Robertson, Merck · Christine Bizet, Merck · Inigo De La Fuente, Merck · Alexandre Laly, Merck · Arban Zahiti, Merck · Rui A. Sousa, Stemmatters · Hakan Goker, M Ventures · Frederic Tonglet, Conveyxo · Tom Edwardson, Procavea Biotech · Richard Day, Luna Therapeutics · Natascha Missbach, Nagene · Karl Brune, Navira Bio

Talk · Presenting Companies (Theatre A)

Immuno-Oncology: Progeneer

Chul Kim, Progeneer

Talk · Presenting Companies (Theatre B)

Drug Discovery and Development: YATREX

Yahya Salem, YATREX

Panel · Therapeutic Insights · Therapeutic Insights Stage

The next oncology winners: Where investors, pharma and biotech are placing their bets

Linda Pullan, Pullan Consulting · Matthias Alder, SRTD Biotech · Anja Bitterwolf, Debiopharm · Lene Gerlach, Women in Life Science Denmark (WiLD) · Alan Rigby, Epitopea

Talk · Presenting Companies (Theatre A)

Immunology: CAGE Bio Inc.

Nitin Joshi, CAGE Bio Inc.

Talk · Presenting Companies (Theatre B)

Drug Discovery and Development: 3billion

Pavel Printsev, 3billion

Talk · Business of Biotech · Business of Biotech Stage

Beyond the Race to IND: Balancing Speed, Risk and Future Value

Raymond Donninger, Lonza

Talk · Presenting Companies (Theatre A)

Immuno-Oncology: Asgard Therapeutics

Cristiana Pires, Asgard Therapeutics

Talk · Presenting Companies (Theatre B)

Drug Discovery and Development: Chugai Pharmaceutical Co., Ltd.

Yutaka Matsuda, Chugai Pharmaceutical Co., Ltd.

Talk · Presenting Companies (Theatre A)

Immuno-Oncology: Mustbio

Jun-Eui Park, Mustbio

Talk · Presenting Companies (Theatre B)

Drug Discovery and Development: ATB Antivirals Ltd

Preethy Paul, ATB Antivirals Ltd

Panel · Business of Biotech · Business of Biotech Stage

Fuelling Innovation: The State of Early-Stage Investment in Biotech

Orsolya Symmons, European Innovation Council · Lovisa Backemar, Eir Ventures · Juri Bach, HTGF · Rabab Nasrallah, Earlybird Venture Capital · Karl Naegler, Sofinnova Partners · Bonnie van Wilgenburg, Bioqube Ventures

Talk · Presenting Companies (Theatre A)

Immuno-Oncology: Pathios Therapeutics Limited

Paul Higham, Pathios Therapeutics Limited

Talk · Presenting Companies (Theatre B)

Cell and Gene Therapies: CARBio Therapeutics

Heonju Lee, CARBio Therapeutics

Panel · Therapeutic Insights · Therapeutic Insights Stage

Cell and Gene Therapy: What Should You Know?

Kirsten Broeckers, Novartis Gene Therapies and AveXis · Lucia Faccio, Sofinnova Partners · Ralf Huss, BioM Biotech Cluster Development · Caroline Man Xu, VeonGen

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

Building the Next Global Biotech Hubs: What Makes an Innovation Ecosystem Work?

Jo Shorthouse, 59 North Communications · Tanja Bloser, Gateway Startup Factory NRW · Imran Nasrullah, CSL Behring · Joao Ribas, Novo Holdings · Ester Sklarsky, Sound Bioventures · Michael Hubner, Johnson & Johnson Innovation

Talk · Presenting Companies (Theatre A)

Cardiovascular, CNS: Vasthera Co., Ltd.

Sang Won Kang, Vasthera Co., Ltd.

Talk · Presenting Companies (Theatre B)

Drug Discovery and Development: Topia Life Science

Aurore Lejeune-Dodge, Topia Life Science

Talk · Presenting Companies (Theatre A)

Immuno-Oncology: NEC Bio B.V.

Heinz Lubenau, NEC Bio B.V.

Talk · Presenting Companies (Theatre B)

Microbiome: Basecamp Research

Valerio Pereno, Basecamp Research

Talk · Presenting Companies (Theatre A)

Dermatology: Alphyn Biologics

Neal Koller, Alphyn Biologics

Talk · Presenting Companies (Theatre B)

Technologies and Tools: Inovis AG

Ashlyn Sadrick Stien, Inovis AG

Talk · Presenting Companies (Theatre A)

Dermatology: Uute Scientific Oy

Kari Sinivuori, Uute Scientific Oy

Talk · Presenting Companies (Theatre B)

Drug Delivery: IamFluidics BV

Tom Kamperman, IamFluidics BV

Panel · The Big Picture Plenary Series · The Big Picture Stage

AI in the Lab: Why Greater Efficiency Could Mean More Drugs, Not Fewer Scientists

Melanie Senior, Nature portfolio; Evaluate · David Dellamonica, AstraZeneca · Piotr Surma, Ingenix · Simon Turner, Sofinnova Partners

Networking · Lounge next to the Exhibit Hall Stage, Hall 8

Speed Networking

Networking · BIO-Europe Exhibit Hall 7&8

Exhibit Hall Reception

Talk · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

Chairperson Opening Remarks

Letizia Goretti, Alia Therapeutics

Talk · Regulatory Strategy · Regulatory Strategy Stage

Chair’s Welcome

Rebecca Lumsden, Sanofi

Fireside chat · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

The Future of Biopharmaceutical Manufacturing

Kenneth Bilenberg, Avid Bioservices

Talk · Business of Biotech · Business of Biotech Stage

Pharma Presentation: MSD

John Copeland, MSD

Talk · Clinical Strategy · Clinical Strategy Stage

An Outlook into the Year 2050: Navigating the Future of Efficiency and Innovation

Bernhard Glombitza, Bayer AG

Talk · Ecosystem Innovation · Ecosystem Innovation Stage

RenSuper Workstation: An AI-Driven Antibody Discovery Platform From Target to Antibody Leads in Clicks

Shelly Wang, Biocytogen

Talk · Presenting Companies (Theatre B)

Autoimmune/Inflammation: Genrix Biopharmaceutical Co., Ltd.

Yifeng Jin, Genrix Biopharmaceutical

Panel · Regulatory Strategy · Regulatory Strategy Stage

Accelerating Innovation and Market Exclusivity Through Regulatory Incentives

Rebecca Lumsden, Sanofi · Rainer Becker, European Commission · Ann Lindberg, Swedish Medical Products Agency · Hugh Pullen, Novartis

Panel · Therapeutic Insights · Therapeutic Insights Stage

Networks or neurons: What’s next in CNS dealmaking?

Millie Nelson, Informa · Marine Beurdeley, Servier · Hannah Franklin, Biovance Capital · Olga Krylova, Otsuka · Jack O'Meara, Aerska · Adam O'Neil, Acadia

Talk · Business of Biotech · Business of Biotech Stage

Pharma Presentation: Merck

Colette Lipp, Merck

Talk · Presenting Companies (Theatre B)

Antibodies: Toursynbio

Yuguang Wang, Toursynbio

Fireside chat · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

From Clinical Success to Commercial Readiness: Strategic Lessons in Bringing Advanced Therapies to Patients

Willem-Jan Blok, Miltenyi Biomedicine

Talk · Business of Biotech · Business of Biotech Stage

Pharma Presentation: Boehringer Ingelheim

Oliver Kast, Boehringer Ingelheim

Talk · Clinical Strategy · Clinical Strategy Stage

Before the Deal: What Western Buyers Must Resolve About China-Origin Evidence and Policy Risk

Chenchao Liu, SILREAL GmbH

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

Biopharma Ecosystem Germany: Spotlight on Innovation Drivers Ready for Take-Off

Gabriel Flemming, Germany Trade & Invest · Susanne Gulden, Rentschler Biopharma SE · Martin Krauss, FGK Clinical Research · Markus Lang, CD4 Therapeutics · Guido Mathews, Phinomics

Talk · Presenting Companies (Theatre B)

Midsize Pharma: Sinovoy Health Group

Thad Huston, Sinovoy Health Group

Talk · Business of Biotech · Business of Biotech Stage

Pharma Presentation: Sanofi

Olaf Ritzeler, Sanofi

Panel · Clinical Strategy · Clinical Strategy Stage

China’s Clinical Revolution: From Regional Player to Global Innovation Engine

Chenchao Liu, SILREAL GmbH · Stella Gu, Tigermed Swiss AG · Echo Hindle-Yang, MSQ Ventures · Seemi Khan, Alkeus Pharmaceuticals

Talk · Presenting Companies (Theatre B)

Cell and Gene Therapies: NK Bioscience Research Inc.

Michael West, NK Bioscience Research Inc.

Fireside chat · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

Manufacturing Next-Gen Therapeutics from Advanced Therapy Manufacturing to Novel Modalities

Birk Vanderweeen, Legend Biotech · Alex Bloom, AviadoBio · Paul Bravetti, Brenus Pharma · Joana Correia, Exogenus Therapeutics

Talk · Business of Biotech · Business of Biotech Stage

Pharma Presentation: Almirall

Emma Gasol, Almirall

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

Accelerating Access to Innovative Therapies for European Patients Through Integrated Decision-Making

Tilo Mandry, IGES Institut · Laurent Goux, Krystal Biotech · Erwan Gicquel, Miltenyi Biomedicine GmbH · Tina Taube, EFPIA · Bettina Ziegele, Paul Ehrlich Institute

Panel · Regulatory Strategy · Regulatory Strategy Stage

Regulatory Updates for Orphan and Pediatric Medicines

Katherine Tyner, Johnson & Johnson

Panel · Therapeutic Insights · Therapeutic Insights Stage

Cardiometabolic innovations beyond GLP-1 – Where are we now?

Olivia Cavlan, LifeArc · Hamza Bokhari, Atrogi · Philip Brainin, IsoMab · Willem Broekaert, V-Bio Ventures · Eva Dahlen, Novo · Philip Janiak, Corteria Pharmaceuticals

Talk · Business of Biotech · Business of Biotech Stage

Pharma Presentation: Debiopharm International SA

Damian Carvajal Ibanez, Debiopharm International SA

Talk · Business of Biotech · Business of Biotech Stage

Pharma Presentation: Servier

Marine Beurdeley, Servier

Fireside chat · Regulatory Strategy · Regulatory Strategy Stage

Addressing Unmet Medical Needs in Europe’s Evolving Pharmaceutical Landscape

Sara Escola, PTC Therapeutics · Stefano Romanelli, EUCOPE

Fireside chat · Business of Biotech · Business of Biotech Stage

From Partnering Pioneer to Global Biotech Leader: The Next Chapter for European Innovation

Hannah England, Ropes & Gray · Margarida Duarte, Genmab

Talk · Ecosystem Innovation · Ecosystem Innovation Stage

Unlocking Japan: Opportunities for Global Biotech to Access and Navigate the Japanese Market

Takashi Kawaguchi, JETRO · Rikako Morishita, METI Kansai · Wakako Toga, National Cancer Center Japan (NCCJ)

Panel · The Big Picture Plenary Series · The Big Picture Stage

Women’s Health: Healthcare’s Largest Underserved Market and Biggest Growth Opportunity

Anastasiya Markvarde, Eir Accelerator · Dana Burduja, European Investment Bank (EIB) · Jessica Federer, Women's Health Fund · Kelle Moley, Eli Lilly and Company · Melindah Sharma, Harvard University · Marie Teil, UCB

Talk · Relax and Learn (Theatre A)

partneringONE power up workshop

Asha Ibrahim, partneringOne

Panel · Industry Voices · Industry Voices Stage

Women’s Health at an Inflection Point: Redefining Treatment, Regulatory Pathways and Access

Karen Chan, Eli Lilly and Company · Kelle Moley, Eli Lilly and Company · Anouk Petersen, McKinsey & Company · Stasa Stankovic, OvartiX · Stephane Thiroloix, Apikal Therapeutics · Lea Wenger, Cyclana Bio

Talk · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

Biologics Manufacturing Excellence

Ali Mohamed, Immatics · Cecile Brocard, Boehringer Ingelheim RCV GmbH & Co KG · Mark Eccleston, Valirx · Lena Romander, Pfizer · Hubert Scholze, Rezon Bio

Keynote · Business of Biotech · Business of Biotech Stage

Keynote: Day in the Life of an experienced dealmaker

Anton Gueth, EVOLUTION Life Science Partners · Evonne Sepsis, ESC Advisors · Anja Harmeier, Roche Ventures · Jenny Laird, Eli Lilly and Company · Nathalie ter Wengel, Pfizer

Panel · Clinical Strategy · Clinical Strategy Stage

Unlocking APACs Clinical Trials Potential: Navigating Regulatory Pathways, Bridging Strategies and Market Access Across the Region

Barbara Kienast, Graythan Regulatory Services

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

Building Biotech Companies, Not Just Funding Them

Natalya Baltrukovich, BackingHerVenture e.V. · Ayokunmi Ajetunmobi, Pioneer Group · Simon Boulton, Altx Therapeutics · Johanna Roostalu, BioInnovation Institute (BII) · Bobby Soni, Slingshot Therapeutics

Talk · Presenting Companies (Theatre A)

CNS/Neurology: AndzonBio2

Simon Loiodice, AndzonBio2

Talk · Presenting Companies (Theatre B)

Technologies and Tools: Avenue Biosciences

Tero-Pekka Alastalo, Avenue Biosciences

Panel · Regulatory Strategy · Regulatory Strategy Stage

Aligning with Regulators to Propel Innovation

Leonor Enes, European Medicines Agency · Wiebke Lobker, BfArM · Laura Oliveira, MSD

Talk · Presenting Companies (Theatre A)

CNS/Neurology: Avecho Biotechnology

Paul Gavin, Avecho Biotechnology

Talk · Presenting Companies (Theatre B)

Technologies and Tools: Infinite d.o.o.

Janez Strancar, Infinite d.o.o.

Talk · Presenting Companies (Theatre A)

CNS/Neurology: Monument Tx

Jenny Barnett, Monument Tx

Talk · Presenting Companies (Theatre B)

Technologies and Tools: KANTIFY

Segolene Martin, KANTIFY

Talk · Presenting Companies (Theatre A)

CNS/Neurology: Tiziana Life Sciences

Ivor Elrifi, Tiziana Life Sciences

Talk · Presenting Companies (Theatre B)

Technologies and Tools: Pavonis

Todd McMullen, Pavonis

Panel · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

Future-proofing Manufacturing for Commercialization of Allogeneic Cell Therapies: From Phase II to Global Commercialization

Lindsay Davies, NextCell Pharma

Fireside chat · Business of Biotech · Business of Biotech Stage

Faster, Sharper, More Competitive: How Pharma BD Is Evolving and How Biotechs Can Keep Pace

Sadiqa Mahmood, Prudentia Sciences · Nuno Alves, Astellas Pharma · Debbie Drane, CSL

Fireside chat · Clinical Strategy · Clinical Strategy Stage

Navigating the Evolving Regulatory Landscape: Strategies for Clinical Success in an Era of Transformation

Sinan Sarac, Parexel · Zoltan Magyarics, AOP Health

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

Korea's Next Wave: Biotech Innovators to Watch

Aline Noizet, Startup Colors · Hyunwoo Lee, KPBMA · Gunsik Cho, Cellweaverse Co., Ltd. · Jongsuep Baek, BeNature BioLab · Yeumin Solomon Yun, Megalab Co., Ltd. · Dongho Shin, MVRIX · Sungjun Yoon, CellNBetter Inc.

Talk · Industry Voices · Industry Voices Stage

EIC VentureMatch Pitching on Health Biotech

Lina Hacker, Boston Consulting Group

Talk · Presenting Companies (Theatre A)

CNS/Neurology: BIORCHESTRA Co., Ltd.

Branden(Jin-hyeob) Ryu, BIORCHESTRA Co., Ltd.

Talk · Presenting Companies (Theatre B)

Technologies and Tools: Constellate Proteomics

Carlos de Lannoy, Constellate Proteomics

Panel · Regulatory Strategy · Regulatory Strategy Stage

Harnessing Regulatory Sandboxes to Drive Innovation in Novel Therapeutics & Technologies

Maren von Fritschen, University of Applied Sciences · Niklas Blomberg, Innovative Health Initiative · Falk Ehmann, European Medicines Agency · Dominika Misztela, CSL Behring

Panel · Therapeutic Insights · Therapeutic Insights Stage

Immunology under the microscope: New frontiers

Sam Possemiers, MRM Health · Renee Aguiar-Lucander, Hansa Biopharma · Samuel Black, Merck KGaA · Giulia Vestri, Claris Ventures

Talk · Presenting Companies (Theatre A)

Antibodies: A-Alpha Bio

David Younger, A-Alpha Bio

Panel · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

Intellectual Property Strategy in Early-Stage Biomanufacturing: Building Competitive Advantage from Day One

Natalia Wright, UCB

Panel · Business of Biotech · Business of Biotech Stage

The Next Generation of European Entrepreneurs: From Scientific Innovation to Life Sciences Impact

Mike Ward, Decision Resources Group, part of Clarivate · Martha Smets, ATHOS · Jonathan Talbot, Melodia Therapeutics

Fireside chat · Clinical Strategy · Clinical Strategy Stage

Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic

Lisa Nelson, Scientia Clinical Research Ltd · Matthew Bugg, MaH Pharma Pty Ltd · Morgan Evans, Agilex Biolabs · Teresa Karnatz, Biocina Pty Ltd · Meredith Manuel, Avion CRO & Imaging Specialists

Fireside chat · Ecosystem Innovation · Ecosystem Innovation Stage

Investing in Women’s Health: How Can Europe Scale Innovation?

Dana Burduja, European Investment Bank (EIB) · Mathilde Cournut, European Commission · Valeria Iansante, European Investment Bank (EIB)

Fireside chat · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

Scaling Biologics Manufacturing in a Changing World: How Biopharma is Rethinking Launches, Partnerships and Resilience

Jennifer Smith-Parker, BioSpace · Cristina Grigore, Lonza

Panel · Business of Biotech · Business of Biotech Stage

Scaling Success: The Dynamics of Late-Stage Investment in Biotech

Sukaina Virji, Camarco (APCO) · Zina Affas Besse, BNP Paribas Asset Management · Hubert Birner, TVM Capital · Magdalena Jonikas, JEITO · Tim Lohoff, Forbion · Cedric Moreau, Sofinnova Partners

Panel · Clinical Strategy · Clinical Strategy Stage

Expanding Global Clinical Trials: Opportunities and Challenges in Emerging Markets

Maya Zlatanova, TrialHub

Fireside chat · Ecosystem Innovation · Ecosystem Innovation Stage

Inside the Incubator: What It Really Takes to Build a Biotech Company Today

Ruth Shah, Bayer · Massa Shoura, Phinomics

Panel · Meet the EMA · Conference Room E (Level 2)

Meet the EMA

Fireside chat · Regulatory Strategy · Regulatory Strategy Stage

Mastering the Shifting Regulatory Landscape: Leveraging the Biotech Act for Innovation and Global Success

Simon Bennett, Biogen · Marco Rafael, Roche

Panel · Therapeutic Insights · Therapeutic Insights Stage

Longevity – Are we getting younger?

Phil Newman, Longevity Technology · Clara Campas, Asabys · Pedro de Noronha Pissarra, Chrysea Limited · Carina Kern, LinkGevity · Nikolaj Kulahin Roed, Novo

Panel · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

Accelerating Innovation: Creating the Right Environment for Success in Biopharma Partnerships

Matthias Mullenborn, Novo

Fireside chat · Clinical Strategy · Clinical Strategy Stage

Unlocking Europe as a Clinical Trials Hub: Delivering Trials at Scale Through Strategic Site Optimization and Operational Excellence

Pilar De la Rocha Mur, BeOne Medicines · Paul Miller, Optimapharm

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

China’s Biotech Revolution: Innovation and Global Impact

Philip Coxon, Insmed · Alicia Hong, BioNTech SE · Xueming Qian, Transcenta · Jia Zhuang, ATLATL Ventures

Panel · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

Strategic Biomanufacturing in China: Navigating Opportunities and Partnerships in a Dynamic Market

Dan Zhang, Peking Union Innovation Hub

Panel · Business of Biotech · Business of Biotech Stage

Capital, Creativity, and Optionality: The New Anatomy of Life Sciences Transactions

Hannah England, Ropes & Gray · Matthew Byron, Ropes & Gray · Nuno Alves, Astellas Pharma · David Bryant, Healthcare Royalty Partners · Kalpana Gupta, Regeneron

Panel · Clinical Strategy · Clinical Strategy Stage

AI and Innovation in Clinical Trials: Transforming Operations and Accelerating Development

Murali Nair, PharmSky Research · Sougato Das, TransPerfect · Paul Little, Atrogi · Jane Twitchen, Biogen

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

At the Board Table: Navigating Power Dynamics and Building Senior Stakeholder Trust (In collaboration with YVC)

Melina Hoffmann, Syncona · Olivia Cavlan, LifeArc · Jean-Philippe Combal, Vivet Therapeutics · Maureen Deehan, Neohla Bio · Anastasiya Sybirna, JEITO

Panel · Regulatory Strategy · Regulatory Strategy Stage

Unlocking Clinical Trial Systems

Raun Kupiec, R Kupiec Consulting · Claire Browne, Parexel · Christine Mayer-Nicolai, Merck KGaA · Hannie Munnik, AstraZeneca

Panel · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

The Role of Innovation in Biopharma Growth

Tim Horlacher, Bayer

Panel · The Big Picture Plenary Series · The Big Picture Stage

Resilient by Design: Reinventing Biopharma Alliances in a Fragmenting World

Helena Smolak, Handelsblatt · Regina Hodits, Angelini Ventures · Deepa Talpade, Bayer · Christian Wojczewski, Evotec · Steve Yang, WuXi AppTec

Networking · Exhibit Halls 7 & 8

Bubbly Reception

Networking · Lounge next to the Exhibit Hall Stage, Hall 8

Speed Networking

Networking · 1st floor foyer Congress Center (near Press Room)

YVC/BD&L peers Reception

Networking · E-Werk & Palladium

Evening Networking Reception

Talk · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

Chairperson Opening Remarks

Jennifer Smith-Parker, BioSpace

Talk · Regulatory Strategy · Regulatory Strategy Stage

Chair’s Opening Remarks

Maren von Fritschen, University of Applied Sciences

Panel · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

Sustainability & Innovation: Transforming Biopharma Partnerships for a Greener Future

Magnus Bjorsne, AstraZeneca

Panel · Business of Biotech · Business of Biotech Stage

How is the APAC region reshaping global biopharma?

Matthew Pullan, Informa · John Copeland, MSD · Thad Huston, Sinovoy Health Group · William Pay, HK WinHealth Pharma Group · Uli Stilz, Flagship Pioneering

Fireside chat · Clinical Strategy · Clinical Strategy Stage

Learning from Failures and Successes in Clinical Trials

Astrid Paneda, Allinky Biopharma · Rahul Agrawal, Cereno Scientific · Benjamin Vandendriessche, Digital Medicine Society (DiMe)

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

The Global Biotech Landscape: Bridging Innovation Across Italy, Germany and Beyond

Piergiorgio Alotto, Embassy of Italy in Berlin · Pietro Gatti, Human Technopole · Alessandro Caforio, University Campus Bio-Medico of Rome

Fireside chat · Regulatory Strategy · Regulatory Strategy Stage

From NAMs (New Approach Methodologies) Innovation to Regulatory acceptance: Accelerating human-relevant modelling

Marco Straccia, FRESCI · Philip Hewitt, Merck KGaA · Reyk Horland, TissUse GmbH · Milena Mennecozzi, European Commission · Ole Olesen, European Commission · Joana Portela, European Medicines Agency · Orsolya Symmons, European Innovation Council

Panel · Therapeutic Insights · Therapeutic Insights Stage

Beyond the inhaler: The respiratory market

Pietro Puglisi, Claris Ventures · Akis Andrianos, Chiesi · Jimmie Hofman, Vicore Pharma · Campbell Stewart, Novo Holdings

Panel · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

Start-Up Strategy for Biomanufacturing Success

Massimiliano Cesarini, Biogenera SpA

Talk · Clinical Strategy · Clinical Strategy Stage

Bridging Therapeutic Areas: Navigating the Oncology–Autoimmune Convergence in Cellular Therapies

Tobias Kampfenkel, Miltenyi Biomedicine

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

The State of Biopharma Deal-Making in 2026: Global Trends & Strategic Shifts

Chad Wessel, Biotechnology Innovation Organization (BIO)

Talk · Presenting Companies (Theatre A)

Drug Delivery: BeNatureBioLab

Jongsuep Baek, BeNature BioLab

Fireside chat · Clinical Strategy · Clinical Strategy Stage

What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad

Jovana Milosevic, Alithia Life Sciences Pty Ltd · Stefan Cross, Crux Biolabs · Sophie Papaconstantinou, CMAX Clinical Research · Kurt Lackovic, Cancer Trials Australia · Leanne Weekes, Bellberry Limited

Panel · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

A Highly Intensified Manufacturing Platform for Rapid Development of Next-Generation Biologics

Nick Hutchinson, Just - Evotec Biologics

Panel · Business of Biotech · Business of Biotech Stage

Saudi Arabia’s Role in Shaping the Future of Biotech

Andre Hofmann, leap:up GmbH · Bandar Al Knawy, Ministry of National Guard Health Affairs (MNGHA) & President, King Saud bin Abdulaziz University for Health Sciences & King Abdullah International Medical Research Center

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

Most Favoured Nations: A Game-Changer for Biotech Dealmaker?

Alexander Natz, EUCOPE · Dierk Neugebauer, Bristol-Myers Squibb · Gregor Strauch, Boehringer Ingelheim Corporate Center

Fireside chat · Regulatory Strategy · Regulatory Strategy Stage

AI Regulations: Driving Innovation While Navigating Compliance

Mariam Jamali, Bayer · Frank Petavy, European Medicines Agency (EMA) · Marc Vandemeulebroecke, Bayer

Panel · Therapeutic Insights · Therapeutic Insights Stage

Envisioning the future of ophthalmology

Suguna Rachakonda, MICRO CRISPR · Peter Benz, Boehringer Ingelheim · Natalia Misciatelli, AAVantgarde · Sara Secall, Inveready · Prabhu Velusami, Johnson & Johnson Innovation

Talk · Presenting Companies (Theatre A)

Technologies and Tools: CellNBetter Inc.

Sungjun Yoon, CellNBetter Inc.

Talk · Business of Biotech · Business of Biotech Stage

Exploring Biotech Opportunities in Saudi Arabia

Talk · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

From Innovation to Scalable Manufacturing: Closing the Gap

David Honba, BioWin, Health Innovation Cluster of Wallonia · Nicolas Rousseau, EVerZom · Vincent Bischoff, Superbranche · Jason Conner, Cellistic · Thomas Schmid, Fraunhofer IZI

Fireside chat · Clinical Strategy · Clinical Strategy Stage

Building a Clinical Strategy for Rare Disease Therapeutics

Astrid Paneda, Allinky Biopharma · Thomas Jaecklin, Gibela Therapeutics · Ermir Kalaj, Cellula Therapeutics SA

Panel · Business of Biotech · Business of Biotech Stage

Partnering for Progress: Unlocking Biotech Opportunities in the Middle East

Ramy Elfeky, Tahaluf · Sarah Aref, Saudi Ministry of health · Nadin Almosnid, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS)

Fireside chat · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

Collaborative Innovation in CDMO Partnerships

Denes Zalai, Eleva Biologics · Marion Hitchcock, Bayer · Ashiq Khan, Evotec

Panel · Business of Biotech · Business of Biotech Stage

Funding Outside the Box: Alternative Financing Strategies for Startups

Nnenna Ohaka, BioXconomy · Andrew Logerfo, HealthCare Royalty · Joey Mason, Claret Capital Partners · Dimitrios Weedon, OrbiMed

Panel · Clinical Strategy · Clinical Strategy Stage

Capital with a Mission: Investing Beyond Traditional Venture Models

Ermir Kalaj, Cellula Therapeutics SA · Jean-Marc Le-Doussal, Remora Biotech · Poul Sorensen, Argobio Studio

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

AI-Powered Ecosystems: Transforming Drug Discovery Through Digital Collaboration

Barnaby Pickering, 59 North Communications · Karim Galzahr, OKG Capital · Fabian Scheugenpflug, Earlybird Venture Capital · Maria Teresa Perez Zaballos, endogene.bio · Jue Wang, Insilico Medicine

Fireside chat · Regulatory Strategy · Regulatory Strategy Stage

EU MDR & IVDR: What to Know to Stay Ahead

Hilary Jones, Consultant and formerly BioNTech · Olga Van Grol-Lawlor, Boston Scientific

Panel · Therapeutic Insights · Therapeutic Insights Stage

Beyond the surface: The rise and future of dermatology

Hubert Truebel, DEBRA Research · Remi Droller, Kurma Partners · Natalie Garzorz-Stark, Dermagnostix · Volker Koscielny, Almirall

Talk · Regulatory Strategy · Regulatory Strategy Stage

What is the Future of Real-World Evidence (RWE) in Europe?

Vladimir Murovec, Osborne Clarke

Talk · Clinical Strategy · Clinical Strategy Stage

Collaborations in Clinical: Building Strong Partnerships that Put Patients First

Kayleigh Rogers, Siteworks Clinical Research

Panel · Biomanufacturing Strategy · Biomanufacturing Strategy Stage

What's Next for Biomanufacturing Strategies?

Steven Howe, Resolution Therapeutics · Michael Moehlen, Valneva · Federico Pollano, IDT Biologika · Michela Silacci Melkko, Johnson & Johnson

Fireside chat · Regulatory Strategy · Regulatory Strategy Stage

HTA Regulation: Early Insights and Reimbursement Implications

Inka Heikkinen, Lundbeck · Matias Olsen, EUCOPE

Panel · Ecosystem Innovation · Ecosystem Innovation Stage

BIO-Europe Media Round-Up: The Stories Shaping Biopharma Right Now

Millie Nelson, Informa · Anette Breindl, BioWorld

Networking · Ecosystem Innovation Stage

Host Handover

Networking · Lounge opposite the Ecosystem Innovation Stage

Farewell Toast